NorthWest Biotherapeutics Inc (NWBO)

[red57dryad]

Merk's $40B buy out of SGEN may be in trouble according to an article today. In the article it is reported Merk is waiting on the results of one of SGEN's clinical trials with an antibody conjugate. The history of antibody conjugates is very "iffy". So much potential but it just didn't seem to hit the nail on the head.. so to say, just so much variation in tumor tissue. that being said, Merk may very well come a calling with "an offer I can't refuse", I don't understand why Merk hasn't already pulled the trigger. The longer they wait, the higher the final price will be. That's what happens when you got something like Ketruda and you think you can do no wrong - it's just human nature to get overly confident in your own abilities when everything seemingly is going your way. I see no way out for Merk - they must try to buy DCVAX technology... "The first patent protecting for Keytruda will expire in 2028, leaving Merck open to generic competition."